Nanobody screening and machine learning guided identification of cross-variant anti-SARS-CoV-2 neutralizing heavy-chain only antibodies

Authors

Peter R. McIlroy, Sandia National Laboratories
Zhuoming Liu, Washington University School of Medicine in St. Louis
Sean Whelan, Washington University School of Medicine in St. Louis
et al.

Journal

PLoS Pathogens

Publication Date

1-1-2025

Volume

21

Issue

1

First Page

e1012903

Document Type

Open Access Publication

DOI

10.1371/journal.ppat.1012903

Rights and Permissions

McIlroy PR, Pham LTM, Sheffield T, Stefan MA, Thatcher CE, Jaryenneh J, Schwedler JL, Sinha A, Sumner CA, Jones IKA, Won S, Bruneau RC, Weilhammer DR, Liu Z, Whelan S, Negrete OA, Sale KL, Harmon B. Nanobody screening and machine learning guided identification of cross-variant anti-SARS-CoV-2 neutralizing heavy-chain only antibodies. PLoS Pathog. 2025 Jan 23;21(1):e1012903. doi: 10.1371/journal.ppat.1012903. © 2025 McIlroy et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Recommended Citation

McIlroy, Peter R.; Liu, Zhuoming; Whelan, Sean; and et al., "Nanobody screening and machine learning guided identification of cross-variant anti-SARS-CoV-2 neutralizing heavy-chain only antibodies." PLoS Pathogens. 21, 1. e1012903 (2025).
https://digitalcommons.wustl.edu/oa_4/4835

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.